Tuberculosis vaccine trials

被引：0

作者：

von Reyn, CF ^{[1
]}

机构：

[1] Dartmouth Hitchcock Med Ctr, Sect Infect Dis & Int Hlth, Lebanon, NH 03756 USA

来源：

LANCET INFECTIOUS DISEASES | 2005年 / 5卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：132 / 132

页数：1

共 50 条

[21] A vaccine for tuberculosis
Farrell, Alison
NATURE MEDICINE, 2018, 24 (11) : 1637 - 1637
[22] A vaccine for tuberculosis
Alison Farrell
Nature Medicine, 2018, 24 : 1637 - 1637
[23] Tuberculosis Vaccine
Hampton, Tracy
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (21): : 2350 - 2350
[24] Tuberculosis vaccine
Sarhan, Mohammed A.
SAUDI MEDICAL JOURNAL, 2010, 31 (01) : 9 - 13
[25] Vaccine trials
Farrington, CP
Miller, E
MOLECULAR BIOTECHNOLOGY, 2001, 17 (01) : 43 - 58
[26] MTBVAC: A Tuberculosis Vaccine Candidate Advancing Towards Clinical Efficacy Trials in TB Prevention
Lacamara, Sergio
Martin, Carlos
ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59 (12): : 821 - 828
[27] Vaccine trials
C. P. Farrington
E. Miller
Molecular Biotechnology, 2001, 17 : 43 - 58
[28] Evaluation of vaccines to prevent childhood pneumonia: Lessons relevant to planning tuberculosis vaccine trials
Mulholland, K
CLINICAL INFECTIOUS DISEASES, 2000, 30 : S206 - S209
[29] Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design
Ibango, Hannah B.
Brookes, Roger H.
Hill, Philip C.
Owiafe, Patrick K.
Fletcher, Helen A.
Lienhardt, Christian
Hill, Adrian V. S.
Adegbola, Richard A.
McShane, Helen
LANCET INFECTIOUS DISEASES, 2006, 6 (08): : 522 - 528
[30] Considering human challenge trials for tuberculosis vaccine development (vol 40, pg 173, 2022)
Kleinwaks, Gavriel
Schmit, Virginia
Morrison, Josh
VACCINE, 2022, 40 (29) : 3984 - 3984